Multiple gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions

Journal of Virology

Volumn 87, Issue 3, 2013, Pages 1518-1527

  Gregory, Devon A ^a   Lyddon, Terri D ^a   Johnson, Marc C ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN; METHIONYLGLYCYLCYSTYLISOLEUCYLLYSYLSERYLLYSYLARGINYLLYSYLASPARTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE BINDING; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; PSEUDOTYPING; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS RELEASE;

CELL LINE; GENE PRODUCTS, GAG; HIV-1; HUMANS; LEUKEMIA VIRUS, MURINE; PROTEIN BINDING; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS ASSEMBLY;

EID: 84873050158     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02604-12     Document Type: Article

References (62)

1. Boyko V, Leavitt M, Gorelick R, Fu W, Nikolaitchik O, Pathak VK, Nagashima K, Hu WS. 2006. Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens. Mol. Cell 23:281-287.
2. Browning MT, Schmidt RD, Lew KA, Rizvi TA. 2001. Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J. Virol. 75:5129-5140.
3. Embretson JE, Temin HM. 1987. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line. J. Virol. 61:2675-2683.
4. Lee SK, Boyko V, Hu WS. 2007. Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins. Virology 360:388-397.
5. Poeschla E, Corbeau P, Wong-Staal F. 1996. Development of HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. U. S. A. 93:11395-11399.
6. Rizvi TA, Panganiban AT. 1993. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67:2681-2688.
7. Granoff A, Hirst GK. 1954. Experimental production of combination forms of virus. IV. Mixed influenza A-Newcastle disease virus infections. Proc. Soc. Exp. Biol. Med. 86:84-88.
8. Zavada J. 1982. The pseudotypic paradox. J. Gen. Virol. 63(Pt 1):15-24.
9. Bhattacharya J, Repik A, Clapham PR. 2006. Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes. J. Virol. 80:5292-5300.
10. Bugelski PJ, Maleeff BE, Klinkner AM, Ventre J, Hart TK. 1995. Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1. AIDS Res. Hum. Retrovir. 11:55-64.
11. Cosson P. 1996. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15:5783-5788.
12. Dorfman T, Mammano F, Haseltine WA, Gottlinger HG. 1994. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1689-1696.
13. Freed EO, Martin MA. 1996. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:341-351.
14. Freed EO, Martin MA. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1984-1989.
15. + T lymphocytes. J. Virol. 71:1443-1452.
16. Mammano F, Kondo E, Sodroski J, Bukovsky A, Gottlinger HG. 1995. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69: 3824-3830.
17. Manrique JM, Affranchino JL, Gonzalez SA. 2008. In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein. Virology 374:273-279.
18. Murakami T, Freed EO. 2000. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74:3548-3554.
19. Wyma DJ, Kotov A, Aiken C. 2000. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J. Virol. 74:9381-9387.
20. Yu X, Yuan X, Matsuda Z, Lee TH, Essex M. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:4966-4971.
21. Beaumont E, Vendrame D, Verrier B, Roch E, Biron F, Barin F, Mammano F, Brand D. 2009. Matrix and envelope coevolution revealed in a patient monitored since primary infection with human immunodeficiency virus type 1. J. Virol. 83:9875-9889.
22. Andersen KB, Diep HA, Zedeler A. 2006. Murine leukemia virus transmembrane protein R-peptide is found in small virus core-like complexes in cells. J. Gen. Virol. 87:1583-1588.
23. Jin J, Li F, Mothes W. 2011. Viral determinants of polarized assembly for the murine leukemia virus. J. Virol. 85:7672-7682.
24. Lusso P, di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, DeRocco SE, Kalyanaraman VS, Gallo RC. 1990. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247:848-852.
25. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
26. Jorgenson RL, Vogt VM, Johnson MC. 2009. Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J. Virol. 83:4060-4067.
27. + are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections. J. Virol. 82:5860-5868.
28. Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA. 2000. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74:4839-4852.
29. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, Cicchetti G, Allen PG, Pypaert M, Cunningham JM, Mothes W. 2003. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4:785-801.
30. Johnson MC, Scobie HM, Ma YM, Vogt VM. 2002. Nucleic acidindependent retrovirus assembly can be driven by dimerization. J. Virol. 76:11177-11185.
31. Lucas TM, Lyddon TD, Cannon PM, Johnson MC. 2010. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu. J. Virol. 84:2666-2674.
32. Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J. 1999. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther. 6:715-728.
33. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92:7297-7301.
34. Chesebro B, Wehrly K, Nishio J, Perryman S. 1992. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-celltropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
35. Varthakavi V, Browning PJ, Spearman P. 1999. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:10329-10338.
36. Chesebro B, Britt W, Evans L, Wehrly K, Nishio J, Cloyd M. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
37. Pinter A, Honnen WJ, Tung JS, O'Donnell PV, Hammerling U. 1982. Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology 116:499-516.
38. Scholz I, Still A, Dhenub TC, Coday K, Webb M, Barklis E. 2008. Analysis of human immunodeficiency virus matrix domain replacements. Virology 371:322-335.
39. Wang CT, Zhang Y, McDermott J, Barklis E. 1993. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67:7067-7076.
40. Feher A, Boross P, Sperka T, Miklossy G, Kadas J, Bagossi P, Oroszlan S, Weber IT, Tozser J. 2006. Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease. J. Gen. Virol. 87:1321-1330.
41. Lucas TM, Lyddon TD, Grosse SA, Johnson MC. 2010. Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites. Virology 405:548-555.
42. Green N, Shinnick TM, Witte O, Ponticelli A, Sutcliffe JG, Lerner RA. 1981. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. U. S. A. 78:6023-6027.
43. Accola MA, Strack B, Gottlinger HG. 2000. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74:5395-5402.
44. Zhang Y, Qian H, Love Z, Barklis E. 1998. Analysis of the assembly function of the human immunodeficiency virus type 1 Gag protein nucleocapsid domain. J. Virol. 72:1782-1789.
45. Yuan B, Li X, Goff SP. 1999. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18:4700-4710.
46. Ragheb JA, Anderson WF. 1994. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68:3220-3231.
47. Rein A, Mirro J, Haynes JG, Ernst SM, Nagashima K. 1994. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68:1773-1781.
48. Gonzalez SA, Burny A, Affranchino JL. 1996. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation. J. Virol. 70:6384-6389.
49. Manrique JM, Celma CC, Hunter E, Affranchino JL, Gonzalez SA. 2003. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein. J. Virol. 77:10881-10888.
50. Wang CT, Barklis E. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67:4264-4273.
51. Hogue IB, Grover JR, Soheilian F, Nagashima K, Ono A. 2011. Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane. J. Virol. 85:9749-9766.
52. Khurana S, Krementsov DN, de Parseval A, Elder JH, Foti M, Thali M. 2007. Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains. J. Virol. 81:12630-12640.
53. Krementsov DN, Rassam P, Margeat E, Roy NH, Schneider-Schaulies J, Milhiet PE, Thali M. 2010. HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components. Traffic 11:1401-1414.
54. Ono A. 2010. Relationships between plasma membrane microdomains and HIV-1 assembly. Biol. Cell 102:335-350.
55. Yeager M, Wilson-Kubalek EM, Weiner SG, Brown PO, Rein A. 1998. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc. Natl. Acad. Sci. U. S. A. 95:7299-7304.
56. Houzet L, Gay B, Morichaud Z, Briant L, Mougel M. 2006. Intracellular assembly and budding of the murine leukemia virus in infected cells. Retrovirology 3:12.
57. Basyuk E, Galli T, Mougel M, Blanchard JM, Sitbon M, Bertrand E. 2003. Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles. Dev. Cell 5:161-174.
58. Jin J, Sherer NM, Heidecker G, Derse D, Mothes W. 2009. Assembly of the murine leukemia virus is directed toward sites of cell-cell contact. PLoS Biol. 7:e1000163. doi:10.1371/journal.pbio.1000163.
59. Sandrin V, Cosset FL. 2006. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J. Biol. Chem. 281:528-542.
60. Sandrin V, Muriaux D, Darlix JL, Cosset FL. 2004. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J. Virol. 78:7153-7164.
61. Ako-Adjei D, Johnson MC, Vogt VM. 2005. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into viruslike particles. J. Virol. 79:13463-13472.
62. Fuller SD, Wilk T, Gowen BE, Krausslich HG, Vogt VM. 1997. Cryoelectron microscopy reveals ordered domains in the immature HIV-1 particle. Curr. Biol. 7:729-738.